EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 38 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $991,000 | +1.5% | 100,000 | 0.0% | 0.08% | -1.3% |
Q2 2022 | $976,000 | -0.9% | 100,000 | 0.0% | 0.08% | -14.3% |
Q1 2022 | $985,000 | -0.6% | 100,000 | 0.0% | 0.09% | -28.3% |
Q4 2021 | $991,000 | -0.3% | 100,000 | 0.0% | 0.13% | +0.8% |
Q3 2021 | $994,000 | -0.5% | 100,000 | 0.0% | 0.13% | +77.5% |
Q2 2021 | $999,000 | +230.8% | 100,000 | +233.3% | 0.07% | +144.8% |
Q1 2021 | $302,000 | – | 30,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Exos Asset Management LLC | 50,000 | $502,000 | 0.39% |
Arena Capital Advisors, LLC- CA | 300,000 | $3,020,000 | 0.30% |
MMCAP International Inc. SPC | 250,000 | $2,516,000 | 0.25% |
PERISCOPE CAPITAL INC. | 350,000 | $3,523,000 | 0.14% |
Kepos Capital LP | 175,000 | $1,761,000 | 0.11% |
Ghisallo Capital Management LLC | 150,000 | $1,508,000 | 0.10% |
Shaolin Capital Management LLC | 200,000 | $2,013,000 | 0.08% |
Atalaya Capital Management LP | 40,000 | $402,000 | 0.08% |
Radcliffe Capital Management, L.P. | 200,000 | $2,013,000 | 0.08% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 57,789 | $581,000 | 0.07% |